Categories: BioTechDeliveryEngineeringHealthTechHumanInformationITMedtechPlatformTools
Harnessing single-stranded DNA for precision genome editing.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.08.2024 | Seed | $5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 12.08.2024 | Kano Therapeutics Raises $5M in Seed Funding | Kano Therapeutics, a Cambridge, MA-based biotechnology company advancing single-stranded DNA (ssDNA) as a flexible biomolecule for gene insertions, raised $5M in Seed funding.
The round, which brought the total amount to $7.1M, was led by T... |
| - | Kano Therapeutics | “KANO” |
Reviews 0
